The effect of carbamazepine co-therapy on the extent of MAO-A inhibition by moclobemide in depressed patients

dc.creator	Rakić-Ignjatović, Anita
dc.creator	Miljković, Branislava
dc.creator	Todorović, Dejan
dc.creator	Timotijević, Ivana
dc.creator	Pokrajac, Milena
dc.date.accessioned	2019-09-02T11:20:20Z
dc.date.available	2019-09-02T11:20:20Z
dc.date.issued	2010
dc.identifier.issn	0924-977X
dc.identifier.uri	https://farfar.pharmacy.bg.ac.rs/handle/123456789/1342
dc.publisher	Elsevier Science BV, Amsterdam
dc.rights	restrictedAccess
dc.source	European Neuropsychopharmacology
dc.title	The effect of carbamazepine co-therapy on the extent of MAO-A inhibition by moclobemide in depressed patients	en
dc.type	conferenceObject
dc.rights.license	ARR
dcterms.abstract	Тодоровић, Дејан; Покрајац, Милена; Тимотијевић, Ивана; Миљковић, Бранислава; Ракић-Игњатовић, Aнита;
dc.citation.volume	20
dc.citation.issue	Supplement 3
dc.citation.spage	S373
dc.citation.epage	S374
dc.citation.other	20: -
dc.citation.rank	M21
dc.description.other	23rd ECNP Congress 28 August-1 September 2010 • Amsterdam, the Netherlands
dc.description.other	Affective disorders and antidepressants – Antidepressants (clinical)
dc.identifier.wos	000283687800413
dc.identifier.doi	10.1016/S0924-977X(10)70526-5
dc.type.version	publishedVersion